Belay Diagnostics
Brian Coe is currently the Chief Executive Officer at Belay Diagnostics and an Adjunct Professor of Entrepreneurship at the University of Chicago Booth School of Business. Prior to their current roles, Brian served as Chief Executive Officer at Talis Biomedical Corporation and Litholink / Laboratory Corporation of America. Brian also held the position of Senior Vice-President at The Laboratory Corporation of America. Brian started their career as an Asst. Director Drug Discovery at Genderm. Brian holds an MBA in Finance and Marketing from The University of Chicago Booth School of Business and a BA in Neuroscience and Psychology from Brandeis University.
This person is not in any teams
Belay Diagnostics
1 followers
Belay Diagnostics provides next-gen sequencing to detect aneuploidy and mutations with our cerebrospinal fluid testing platform. Improving diagnosis for brain and spinal cord cancers can give people the best chance for a cure without the need for invasive biopsies. We see our technological advances in cerebrospinal fluid assays as offering clinicians alternative diagnostic tools for use in treatment decisions.